Dana Busschots

1.1k total citations
20 papers, 280 citations indexed

About

Dana Busschots is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dana Busschots has authored 20 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Hepatology and 1 paper in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dana Busschots's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (13 papers). Dana Busschots is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (13 papers). Dana Busschots collaborates with scholars based in Belgium, Netherlands and Germany. Dana Busschots's co-authors include Geert Robaeys, Ger H. Koek, Sven Francque, Rob Bielen, Özgür M. Koc, Frederik Nevens, Pierre Van Damme, Niel Hens, Cécile Kremer and Diana M. Hendrickx and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and BMC Public Health.

In The Last Decade

Dana Busschots

19 papers receiving 275 citations

Peers

Dana Busschots

EPIDE

HEPAT

EDM

Alexis José-Ábrego Mexico

Nazish Butt Pakistan

Giuseppe Barbaro Italy

Feng Su United States

Chandana Pande India

S. Gordon United States

Oidov Baatarkhuu Mongolia

K. Yu. Kokina Russia

Yann Quertainmont France

Alexis José-Ábrego Mexico

Dana Busschots

198 ×0.9

EPIDE

175 ×1.2

HEPAT

23 ×0.6

EDM

35 ×1.2

34 ×1.3

Citations per year, relative to Dana Busschots Dana Busschots (= 1×) peers Alexis José-Ábrego

Countries citing papers authored by Dana Busschots

Since Specialization

Citations

This map shows the geographic impact of Dana Busschots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Busschots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Busschots more than expected).

Fields of papers citing papers by Dana Busschots

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Busschots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Busschots. The network helps show where Dana Busschots may publish in the future.

Co-authorship network of co-authors of Dana Busschots

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Busschots. A scholar is included among the top collaborators of Dana Busschots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Busschots. Dana Busschots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Busschots, Dana, Cécile Kremer, Rob Bielen, et al.. (2022). Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis. BMC Public Health. 22(1). 2159–2159. 15 indexed citations

Koc, Özgür M., Jef Verbeek, Ger H. Koek, et al.. (2022). A long-term study of liver-related events in Caucasian hepatitis B patients with normal ALT values and high viremia. Acta Gastro Enterologica Belgica. 85(1). 56–61. 3 indexed citations

Busschots, Dana, Erwin Ho, Sarah Blach, et al.. (2022). Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach. BMC Infectious Diseases. 22(1). 397–397. 1 indexed citations

Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2021). On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. BMC Public Health. 21(1). 1574–1574. 3 indexed citations

Busschots, Dana, et al.. (2021). Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine. 8. 615978–615978. 141 indexed citations

Busschots, Dana, Cécile Kremer, Rob Bielen, et al.. (2021). A multicentre interventional study to assess blood-borne viral infections in Belgian prisons. BMC Infectious Diseases. 21(1). 708–708. 11 indexed citations

Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2021). Hepatitis C reinfection in former and active injecting drug users in Belgium. Harm Reduction Journal. 18(1). 102–102. 2 indexed citations

Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2021). Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in Belgium. Acta Gastro Enterologica Belgica. 84(2). 311–316. 1 indexed citations

Busschots, Dana, Cécile Kremer, Rob Bielen, et al.. (2021). Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium. Harm Reduction Journal. 18(1). 54–54. 3 indexed citations

10.

Busschots, Dana, Cécile Kremer, Özgür M. Koc, et al.. (2021). The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination. International Journal of Infectious Diseases. 105. 217–223. 4 indexed citations

11.

Busschots, Dana, Rob Bielen, Stina Salomonsson, et al.. (2020). Eliminating viral hepatitis C in Belgium: the micro-elimination approach. BMC Infectious Diseases. 20(1). 181–181. 12 indexed citations

12.

Koc, Özgür M., Cécile Kremer, Niel Hens, et al.. (2020). Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium. PLoS ONE. 15(7). e0234740–e0234740. 7 indexed citations

13.

Bielen, Rob, et al.. (2020). Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)—Hepatitis C fingerprick study. Journal of Viral Hepatitis. 27(7). 709–714. 10 indexed citations

14.

Robaeys, Geert, et al.. (2020). The prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus. Journal of Hepatology. 73. S412–S413.

15.

Koc, Özgür M., Geert Robaeys, Rob Bielen, et al.. (2020). Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long‐term observational cohort study. Journal of Medical Virology. 92(12). 3373–3380. 4 indexed citations

16.

Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2020). Viral hepatitis in Belgian prisons: a first-time multicenter prevalence study. Journal of Hepatology. 73. S799–S799. 1 indexed citations

17.

Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2020). The success of outreach hepatitis C screening among a Belgian population of drug users in a rural and urban setting. Journal of Hepatology. 73. S310–S311. 1 indexed citations

18.

Bielen, Rob, Özgür M. Koc, Dana Busschots, et al.. (2019). Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study. BMJ Open. 9(5). e026464–e026464. 11 indexed citations

19.

Koc, Özgür M., Pierre Van Damme, Dana Busschots, et al.. (2019). Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017. Eurosurveillance. 24(30). 35 indexed citations

20.

Bielen, Rob, Cécile Kremer, Özgür M. Koc, et al.. (2018). Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium?. Liver International. 39(4). 667–675. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact